Neuroscience
A report from The Guardian about ongoing genetics research in Alzheimer's disease:
Alzheimer's research links three genes to disease
Findings hailed as 'huge step' towards earlier testing and better treatment for Alzheimer's
Ian Sample, science correspondent
guardian.co.uk
Sunday 6 September 2009 18.05 BST
Read the article
- Alzheimer: Clinical Trials Day At The Aaic2015 Conference
Alzheimer's Association Press Release at 0700 hrs EDT on 22 July 2015. - Longer-Term Analysis of Phase 3 Solanezumab (Lilly) Up to 3.5 Years - Biomarker Results from Phase 3 Gantenerumab (Roche) Trial - New Data from Aducanumab (Biogen) Phase 1b...
- Alzheimer's Disease: New Risk Genes Discovered
From Cardiff University News Centre: New Alzheimer’s risk genes discovered in record study 27 October 2013 "In the largest ever study of its kind, an international collaboration of scientists, jointly led by Cardiff, has uncovered 11 new susceptibility...
- Alzheimer's: Differences In Diagnostic Trends
Britain is bottom of Euro league table at diagnosing Alzheimer's Britons with symptoms of Alzheimer’s disease take twice as long to be diagnosed as sufferers living in other European countries, research has found. By Laura Donnelly, Health Correspondent...
- Neuropsychology Abstract Of The Day: Alzheimer Drug Regimens & Delivery Systems
Bassil, N & Grossberg, GT. (2009). Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. CNS Drugs, 23(4), 293-307. The mainstay of current management of patients with Alzheimer's disease involves drugs that...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...
Neuroscience
Alzheimer's Disease: Advances in Genetic Understanding
A report from The Guardian about ongoing genetics research in Alzheimer's disease:
Alzheimer's research links three genes to disease
Findings hailed as 'huge step' towards earlier testing and better treatment for Alzheimer's
Ian Sample, science correspondent
guardian.co.uk
Sunday 6 September 2009 18.05 BST
Read the article
- Alzheimer: Clinical Trials Day At The Aaic2015 Conference
Alzheimer's Association Press Release at 0700 hrs EDT on 22 July 2015. - Longer-Term Analysis of Phase 3 Solanezumab (Lilly) Up to 3.5 Years - Biomarker Results from Phase 3 Gantenerumab (Roche) Trial - New Data from Aducanumab (Biogen) Phase 1b...
- Alzheimer's Disease: New Risk Genes Discovered
From Cardiff University News Centre: New Alzheimer’s risk genes discovered in record study 27 October 2013 "In the largest ever study of its kind, an international collaboration of scientists, jointly led by Cardiff, has uncovered 11 new susceptibility...
- Alzheimer's: Differences In Diagnostic Trends
Britain is bottom of Euro league table at diagnosing Alzheimer's Britons with symptoms of Alzheimer’s disease take twice as long to be diagnosed as sufferers living in other European countries, research has found. By Laura Donnelly, Health Correspondent...
- Neuropsychology Abstract Of The Day: Alzheimer Drug Regimens & Delivery Systems
Bassil, N & Grossberg, GT. (2009). Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. CNS Drugs, 23(4), 293-307. The mainstay of current management of patients with Alzheimer's disease involves drugs that...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...